Endogenous NIS expression in triple-negative breast cancers

Annals of Surgical Oncology

Volumn 16, Issue 4, 2009, Pages 962-968

  Renier, Corinne ^a   Yao, Chen ^a   Goris, Michael ^a   Ghosh, Malavika ^a   Katznelson, Laurence ^a   Nowles, Kent ^a   Gambhir, Sanjiv S ^a   Wapnir, Irene ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; IODINE 123; PROGESTERONE; SODIUM IODIDE SYMPORTER;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DOSIMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN EXPRESSION; SCINTIGRAPHY;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SYMPORTERS;

EID: 62149129345     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0280-9     Document Type: Article

References (34)

1. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423
2. JD Brenton LA Carey AA Ahmed C Caldas 2005 Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23 7350 7360
3. LA Carey EC Dees L Sawyer L Gatti DT Moore F Collichio 2007 The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes Clin Cancer Res 13 2329 2334
4. S Cleator W Heller RC Coombes 2007 Triple-negative breast cancer: therapeutic options Lancet Oncol 8 235 244
5. B Kreike MJ van de Vijver 2007 Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response Breast Cancer Res 9 405
6. EA Rakha DS Tan WD Foulkes IO Ellis A Tutt TO Nielsen 2007 Are triple negative tumours and basal-like breast cancer synonymous? Breast Cancer Res 9 R80
7. LA Carey CM Perou CA Livasy LG Dressler D Cowan K Conway 2006 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492 2502
8. R Dent M Trudeau KI Pritchard WM Hanna HK Kahn CA Sawka 2007 Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 4429 4434
9. M van de Rijn CM Perou R Tibshirani P Haas O Kallioniemi J Kononen 2002 Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome Am J Pathol 161 1991 1996
10. TO Nielsen FD Hsu K Jensen M Cheang G Karaca Z Hu 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367 5374
11. JB Arnes JS Brunet I Stefansson LR Begin N Wong PO Chappuis 2005 Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer Clin Cancer Res 11 4003 4011
12. SM Rodriguez-Pinilla D Sarrio E Honrado D Hardisson F Calero J Benitez 2006 Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas Clin Cancer Res 12 1533 1539
13. EA Rakha ME El-Sayed AR Green AH Lee JF Robertson IO Ellis 2007 Prognostic markers in triple-negative breast cancer Cancer 109 25 32
14. BG Haffty Q Yang M Reiss T Kearney SA Higgins J Weidhaas 2006 Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 5652 5657
15. Carlson RW AC, Anderson BO, et al. NCCN Clinical Practice Guidelines in Oncology-Breast Cancer. National Comprehensive Cancer Network 2008, vol. 2; NCCN, Fort Washington, PA; 2008.
16. UH Tazebay IL Wapnir O Levy O Dohan LS Zuckier QH Zhao 2000 The mammary gland iodide transporter is expressed during lactation and in breast cancer Nat Med 6 871 878
17. IL Wapnir M van de Rijn K Nowels PS Amenta K Walton K Montgomery 2003 Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections J Clin Endocrinol Metab 88 1880 1888
18. G Dai O Levy N Carrasco 1996 Cloning and characterization of the thyroid iodide transporter Nature 379 458 460
19. PA Smanik Q Liu TL Furminger K Ryu S Xing EL Mazzaferri 1996 Cloning of the human sodium lodide symporter Biochem Biophys Res Commun 226 339 345
20. B Caillou F Troalen E Baudin M Talbot S Filetti M Schlumberger 1998 Na+/I-symporter distribution in human thyroid tissues: an immunohistochemical study J Clin Endocrinol Metab 83 4102 4106
21. T Kogai Y Kanamoto AI Li LH Che E Ohashi K Taki 2005 Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells Endocrinology 146 3059 3069
22. O Dohan Z Baloch Z Banrevi V Livolsi N Carrasco 2001 Rapid communication: predominant intracellular overexpression of the Na(+)/I(-) symporter (NIS) in a large sampling of thyroid cancer cases J Clin Endocrinol Metab 86 2697 2700
23. M Schlumberger M Tubiana F De Vathaire C Hill P Gardet JP Travagli 1986 Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma J Clin Endocrinol Metab 63 960 967
24. NA Samaan PN Schultz TP Haynie NG Ordonez 1985 Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients J Clin Endocrinol Metab 60 376 380
25. DH Moon SJ Lee KY Park KK Park SH Ahn MS Pai 2001 Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues Nucl Med Biol 28 829 834
26. IL Wapnir M Goris A Yudd O Dohan D Adelman K Nowels 2004 The Na+/I-symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid Clin Cancer Res 10 4294 4302
27. JA Siegel SR Thomas JB Stubbs MG Stabin MT Hays KF Koral 1999 MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates J Nucl Med 40 37S 61S
28. HR Maxon SR Thomas A Boehringer J Drilling MI Sperling JC Sparks 1983 Low iodine diet in I-131 ablation of thyroid remnants Clin Nucl Med 8 123 126
29. K Liang Y Lu W Jin KK Ang L Milas Z Fan 2003 Sensitization of breast cancer cells to radiation by trastuzumab Mol Cancer Ther 2 1113 1120
30. R Bruno P Giannasio G Ronga E Baudin JP Travagli D Russo 2004 Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues J Endocrinol Invest 27 1010 1014
31. O Dohan N Carrasco 2003 Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond Mol Cell Endocrinol 213 59 70
32. S Unterholzner MJ Willhauck N Cengic M Schutz B Goke JC Morris 2006 Dexamethasone stimulation of retinoic acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells J Clin Endocrinol Metab 91 69 78
33. O Dohan A De la Vieja N Carrasco 2006 Hydrocortisone and purinergic signaling stimulate sodium/iodide symporter (NIS)-mediated iodide transport in breast cancer cells Mol Endocrinol 20 1121 1137
34. KA Knostman JA McCubrey CD Morrison Z Zhang CC Capen SM Jhiang 2007 PI3 K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer BMC Cancer 7 137